Breast Cancer 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Breast Cancer trials.

Effective solutions for advancing Breast Cancer research

Breast cancer affects more women worldwide than any other cancer. Despite its prevalence, studying and improving treatment is extremely complex. Oncology studies often involve multiple cohorts, tumor types, scattered sites, and expensive medications. More importantly, breast cancer patients face debilitating symptoms that can make participation in studies difficult. That's where Signant's evidence generation solutions and deep oncology experience can help.

Breast Cancer-1

Why Signant Health

  • Capture Accurate Data & Incorporate PROMS
  • Place the Patient First
  • Gain Richer Insights
  • Simplify the Consent Process
  • Optimize Supply Management
  • Digitalize the Entire Process
  • Capture Accurate Data & Incorporate PROMS

    Capture Accurate Data & Incorporate PROMS

    Leverage our leading digital solutions as well as extensive clinical and eCOA science expertise to capture high-quality, reliable endpoint data. And with our deep understanding of recent FDA guidance on the use of patient-reported outcomes in oncology trials, we're prepared to help you incorporate patients' perspectives in your data capture strategy. 
     

  • Place the Patient First

    Place the Patient First

    Our patient-focused approach is embedded in everything from the software to the eCOA instruments’ overall designs. For example, thoughtfully migrating instrument layouts to electronic formats to ensure ease of use, such as larger, well-spaced buttons compensate for treatment-related finger numbness.
     

  • Gain Richer Insights

    Gain Richer Insights

    With our sensors and wearables, you can collect objective data on sleep and activity patterns, for enhanced insight into the post-treatment recovery associated with each treatment cycle. Pair with our eCOA for a continuous, real-time view of each patients’ health status.
     

  • Simplify the Consent Process

    Simplify the Consent Process

    Signant SmartSignals eConsent uses engaging multimedia to convey complex information and allows patients to flag sections they have questions on. The solution also handles the multiple consents and protocol amendments common in breast cancer trials, limiting the risk of inspection findings.
     

  • Optimize Supply Management

    Optimize Supply Management

    Our Signant SmartSignals RTSM solution uses proprietary algorithms to optimize drug supplies for the different, complex study designs associated with breast cancer trials, and applies randomization adaptations seamlessly.
     

  • Digitalize the Entire Process

    Digitalize the Entire Process

    While all of our solutions can be used as standalone tools, they seamlessly integrate with one another to further enhance the accuracy and efficiency of your breast cancer study.
     

Comprehensive Breast Cancer experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Breast Cancer trial resources
SOLUTION BROCHURE

Breast Cancer Trial Solutions Overview


GET INSIGHTS
VIDEO

Breast Cancer Trial Solutions



WATCH [2 MIN]
CASE STUDY

SmartSignals eConsent Streamlines Complexities in Global Oncology Study

 
READ CASE STUDY

Ready to learn more?

Discover how Signant can support your current or upcoming breast cancer trials.